Figure 1
From: Analysis of inter-patient variations in tumour growth rate
Regression of specific growth rate, SGR, with the logarithm of tumour volume for post-chemotherapy regrowth of NSCLC (p < 0.03) and pre-treatment growth of meningioma tumours (p < 0.01), primary lung cancer (NS), pancreatic carcinoma (NS), hepatocellular carcinoma (NS), and human carcinoid GOT1 tumours in the mouse model (p < 1E-11). NS: Not statistically significant.